Table 3

Proportion of patients who progressed to MSAP or SAP among those who had presented with AP symptoms at hospital admission

Author, year; countryStudy design and settingStudy populationSample size (patients with AP symptoms)MSAP casesSAP cases
NumberProportionNumberProportion (%)
USA studies
 Single-centre hospital
  Bhat et al, 200718; USAProspective cohort; hospitalConsecutive patients with AP admitted to a single hospital within 48 hours of onset of symptoms between June 2003 and January 200591NRNR19*a 20.9
  Koutroumpakis et al, 201719; Koutroumpakis et al, 201420; USAProspective cohort; hospitalPatients with AP enrolled at single centre from 2003 to 20144009423.5%9824.5
  Kwong et al, 201621; USARetrospective cohort; secondary careConsecutive patients admitted with AP to single institution from November 2010 to December 20135146513%15*b 3
  Talukdar et al, 201224; USAProspective cohort study; three hospitalsConsecutive patients with AP presented at a single institution between June 2004 and August 20051372719.7%15*c 10.9
EU-5 studies
 Single-centre hospital
  Gonzelez et al, 201125; UKRetrospective study of prospective data; tertiary referral centrePatients admitted with AP to tertiary referral centre between January 2008 and December 2009127NRNR32*c 25.2
 Multicentre hospital
  De Rai et al, 201034; ItalyProspective cohort; 56 centresNational sample of patients with AP admitted to hospital between July 2002 and December 20111173NRNR167*c 14.2
  Mole et al, 201633; UK†Retrospective cohort; 16 health boardsNational sample of patients admitted to hospital for AP between April 2009 and March 20122053NRNR390*d 19
 ICU setting
  Harrison et al, 200727; UKRetrospective cohort; general critical care unitsICNARC coding219 468NRNR26771.2
  • Only studies with unselected populations for specific characteristics or comorbidities are presented.

  • *Severity assessment criteria: (a) APACHE II and Ranson score, (b) RAC, 2012, (c) Atlanta classification, 1992, (d) clinical presentation.

  • †Study providing information on the size of the subgroup with SAP populations among all those who presented with AP, included for the reporting of epidemiological outcomes.

  • AP, acute pancreatitis; APACHE, Acute Physiology And Chronic Health Evaluation; EU-5, European Union-5; ICNARC, Intensive Care National Audit and Research Centre; ICU, intensive care unit; MSAP, moderately severe acute pancreatitis; NR, not reported; RAC, revised Atlantic classification; SAP, severe acute pancreatitis; UK, United Kingdom; USA, United States of America.